As of Jul 22
| +0.49 / +1.36%|
The 9 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 49.00, with a high estimate of 54.00 and a low estimate of 40.00. The median estimate represents a +34.06% increase from the last price of 36.55.
The current consensus among 9 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.